At HaloScrips, we evaluate GLP-1 spends quarterly
Follow-up labs at 6 to 8 weeks assess initial response
The FDA has issued warnings to companies that have illegally sold drugs labeled for research purposes or not for human consumption. Some of these products have been sold directly to patients for human use, regardless of being specifically labeled not to be used in humans
Furthermore, validation has been achieved with small molecules such as GSK137647A, which activates the Free Fatty Acid Receptor 4 (FFAR4, also known as GPR120), and with Sinigrin, an agonist of the Bitter Taste Receptor 38 (TAS2R38)
2-day UPS shipping with thoughtful packaging (cotton-ball vial stabilization flags real pharmacy hygiene)
Our laboratory teams follow pharmaceutical clean room protocols even when accessing storage inventory, maintaining the same high standards throughout the product lifecycle